학술논문
Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria
Document Type
Article
Author
Larkin, James; Weber, Jeffrey; Del Vecchio, Michele; Gogas, Helen; Arance, Ana M.; Dalle, Stephane; Cowey, C. Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Márquez-Rodas, Iván; Butler, Marcus O.; Di Giacomo, Anna Marie; Middleton, Mark R.; De la Cruz-Merino, Luis; Arenberger, Petr; Atkinson, Victoria; Hill, Andrew; Fecher, Leslie A.; Millward, Michael; Khushalani, Nikhil I.; Queirolo, Paola; Long, Georgina V.; Lobo, Maurice; Askelson, Margarita; Ascierto, Paolo A.; Mandalá, Mario
Source
In European Journal of Cancer September 2022 173:285-296
Subject
Language
ISSN
0959-8049